Dr. Chu Duc Hoang

Innovation

A startup, community innovation platforms, and policy work supporting enterprise technology innovation.

Startup

AI and Raman-spectroscopy skin-cancer screening

Zinmed

Co-founder & Chairman (since 2014)

A non-invasive skin-cancer screening tool combining Raman spectroscopy and artificial intelligence. The ZinRaman-D1 device is under research, targeting ISO 13485 compliance.

Visit zinmed.com
  • Basal cell carcinoma (BCC)
  • Squamous cell carcinoma (SCC)
  • Melanoma
  • Benign lesions

Zinmed bridges the two areas of work: research results from BIRALAB are developed into a digital-health product for the public.

Community platforms

Open platforms serving enterprises, scientists and investors.

Policy and technology-innovation funds

  • More than ten years at the National Technology Innovation Fund (MOST), helping run grants, loans and interest-rate support for enterprises innovating with technology.
  • Contributing to financial mechanisms that support enterprises, including the 2025 Law on Science, Technology and Innovation.
  • Coordinating the Vietnam–Korea Knowledge Sharing Program (KSP) on technology-finance policy.
See career

Community

The projects and platforms on this page are personal and community activities of Dr. Chu Duc Hoang and do not represent the National Technology Innovation Fund or the Ministry of Science and Technology.